Aberrant methylation of APC and RARβ2 genes in breast cancer patients
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in IUBMB Life
- Vol. 67 (1) , 61-68
Abstract
Changes in the status of DNA methylation are one of the most common molecular alterations in human neoplasia. We aimed to identify epigenetic molecular markers in serum for early detection of breast cancer. Authors analyzed retrospectively the methylation status of RARβ2 and APC genes in serum samples from 121 breast cancer patients, 79 patients with benign breast diseases, and 66 healthy volunteers using methylation‐specific PCR. The methylated APC and RARβ2 were significantly higher in breast cancer patients (93.4%, 95.6%) than benign (7.8%, 14.5%) but not detected in healthy volunteers (0%) at (P < 0.0001). Both methylated genes showed no significant difference among clinicopathological factors apart from triple negative breast cancer patients as all of them (χ2 = 7.4, P = 0.007) reported to be methylated RARβ2 genes. Both methylated genes were detected in all grades and stages. Both sensitivities and specificities of the methylated genes for breast cancer detection were superior to traditional tumor markers in detection of breast cancer, early stage, low grade tumors, and triple negative breast cancer patients. Thus methylated APC and RARβ2 genes might be valuable serum‐based molecular markers for early detection of breast cancer. © 2015 IUBMB Life, 67(1):61–68, 2015Keywords
This publication has 17 references indexed in Scilit:
- Detection of aberrant methylation of tumor suppressor genes in plasma from cancer patientsPersonalized Medicine Universe, 2013
- Aberrant Methylation ofRARβ2andAPCGenes in Voided Urine as Molecular Markers for Early Detection of Bilharzial and Nonbilharzial Bladder CancerCancer Epidemiology, Biomarkers & Prevention, 2011
- Methylated genes in breast cancerCancer Biology & Therapy, 2011
- The Staging of Cancer: A Retrospective and Prospective AppraisalCA: A Cancer Journal for Clinicians, 2008
- In situ detection of global DNA hypomethylation in exfoliative urine cytology of patients with suspected bladder cancerExperimental and Molecular Pathology, 2007
- Cancer epigenomics: DNA methylomes and histone-modification mapsNature Reviews Genetics, 2007
- Detection of Aberrant Methylation of Four Genes in Plasma DNA for the Detection of Breast CancerJournal of Clinical Oncology, 2006
- Cell‐free DNA and RNA in Plasma as a New Molecular Marker for Prostate and Breast CancerAnnals of the New York Academy of Sciences, 2006
- Gene Promoter Hypermethylation in Tumors and Plasma of Breast Cancer PatientsCancer Research and Treatment, 2005
- Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients with Renal CancerCancer Research, 2004